Clinical Trial

Electronic Symptoms Reporting During Cancer Treatment

Study Description

Electronic Patient Reporting of Symptoms During Cancer Treatment

The current study is designed to test nationally whether patients' outcomes and utilization of services can be improved through symptom monitoring via patient-reported outcomes between visits.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Patient Self-Reporting of Symptoms

At baseline, CRAs will train patients to self-report symptoms and physical functioning weekly for up to a year, with a choice to do so online or via an automated telephone system. Whenever a concerning symptom is reported, an automated "email alert" notification will be sent to the site CRA. The CRA will forward the alert to the responsible clinical nurse (or other covering clinician) and CC the site's Nurse Champion. Within 72 hours, the CRA will document what action(s), if any, were taken by t ...read more on ClinicalTrials.org

Usual Care Delivery

Patients receive routine cancer care delivery with no additional systematic monitoring of symptoms

Additional Information

Official Study Title

"PRO-TECT" Patient Reported Outcomes to Enhance Cancer Treatment

Clinical Trial ID

NCT03249090

ParticipAid ID

rb2Bvb